SEC 13F Intelligence

Beutel, Goodman & Co Ltd. / EPRX

Beutel, Goodman & Co Ltd.’s Eupraxia Pharmaceuticals Inc Position

Does Beutel, Goodman & Co Ltd. own Eupraxia Pharmaceuticals Inc (EPRX)? Yes3.67M shares worth $26M (+0.18% of its 13F portfolio) as of Q1 2026, down from 3.71M shares the prior filed quarter.

Position Value
$26M
Q1 2026
Shares
3.67M
% of Portfolio
+0.18%
Quarters Held
3
currently held

Position History EPRX

Reported value by quarter
Q3 ’25: $24MQ3 ’25Q4 ’25: $28MQ4 ’25Q1 ’26: $26MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.67M$26M+0.18%
Q4 20253.71M$28M+0.17%
Q3 20254.06M$24M+0.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Beutel, Goodman & Co Ltd.’s full portfolio or all institutional holders of EPRX.